학술논문
Randomised clinical trial: Pemafibrate, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), versus placebo in patients with non-alcoholic fatty liver disease
Document Type
Article
Author
Source
In: Alimentary Pharmacology and Therapeutics . (Alimentary Pharmacology and Therapeutics, November 2021, 54(10):1263-1277)
Subject
Language
English
ISSN
13652036
02692813
02692813